A 0.6% DAX decline masks divergent German stock performances driven by bond yields and ECB policy shifts. - SAP SAP-- ...

Airtel Money, Airtel Africa's mobile-money unit, plans a London IPO to sell $800M in existing shares, not new capital. - The ...

Defence Therapeutics promotes its AccuM platform at ADC conferences, claiming enhanced tumor targeting for antibody-drug ...

A regulator proposing to confiscate the proceeds of a business the target says it does not run is not a dispute over a number ...

Binance lost EU MiCA licensing in Greece but continues operations via Article 61's reverse solicitation clause. - Regulators ...

Danish fund PortfolioManager suspended trading in 2026 due to technical failures and market closures, not financial distress.

Zealand Pharma's obesity drug survodutide achieved 16.6% weight loss in Phase 3 trials but triggered a 20% stock plunge due ...

Regeneron's COURAGE trial reduced muscle loss by 50% when trevogrumab was added to semaglutide, addressing a key GLP-1 drug criticism. - Total weight loss remained unchanged at 10-11%, but fat loss ...

SECZ SECZ--stock surged 133% on SEC's tokenization exemption, despite 5% revenue decline and $21.7M net loss. - The 975x P/E ...

ETF growth relies mostly on price appreciation and a $100M in-kind transfer from its parent company, not fresh investor ...

Retirees rush to convert 401(k)s to Roth IRAs, driven by misleading "everyone's doing it" narratives and inflated Fidelity ...

Two small drones attacked Ethiopia's Bishoftu Air Force base, killing personnel and prompting an indefinite drone ban in ...